The Vanguard Group 13D and 13G filings for Rocket Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:14 pm Purchase |
2023-12-29 | 13G | Rocket Pharmaceuticals, Inc. RCKT |
The Vanguard Group | 5,447,565 6.040% |
1,261,023 (+30.12%) |
Filing |
| 2023-02-09 11:32 am Purchase |
2022-12-30 | 13G | Rocket Pharmaceuticals, Inc. RCKT |
The Vanguard Group | 4,186,542 5.320% |
885,404 (+26.82%) |
Filing |
| 2022-02-10 08:37 am Purchase |
2021-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT |
The Vanguard Group | 3,301,138 5.120% |
3,301,138 (New Position) |
Filing |